These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38597655)

  • 1. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
    Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
    J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease.
    Lewandrowski EL; Turbett SE; Nigrovic LE; Klontz EH; Branda JA
    J Infect Dis; 2024 Aug; 230(Supplement_1):S76-S81. PubMed ID: 39140717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
    Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
    Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
    Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
    J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.
    Sfeir MM; Meece JK; Theel ES; Granger D; Fritsche TR; Steere AC; Branda JA
    J Clin Microbiol; 2022 May; 60(5):e0252821. PubMed ID: 35418241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
    Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Novel Microarray Immunoblot Assay for Detection of IgM- and IgG-Class Antibodies to Borrelia burgdorferi.
    Theel ES; Sorenson M; Granger D
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
    Sabin AP; Scholze BP; Lovrich SD; Callister SM
    Diagn Microbiol Infect Dis; 2023 Jan; 105(1):115837. PubMed ID: 36370542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
    Lipsett SC; Branda JA; Nigrovic LE
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
    Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
    J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
    Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
    Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
    Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.
    Molins CR; Delorey MJ; Sexton C; Schriefer ME
    J Clin Microbiol; 2016 Nov; 54(11):2726-2734. PubMed ID: 27558183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of different standard and modified two-tier testing strategies for the laboratory diagnosis of lyme borreliosis in a European setting.
    Hoeve-Bakker BJA; Kerkhof K; Heron M; Thijsen SFT; van Gorkom T
    Eur J Clin Microbiol Infect Dis; 2024 Dec; 43(12):2397-2406. PubMed ID: 39375250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context.
    Can Commun Dis Rep; 2020 May; 46(5):125-131. PubMed ID: 32558809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Testing for Lyme Disease.
    Kobayashi T; Auwaerter PG
    Infect Dis Clin North Am; 2022 Sep; 36(3):605-620. PubMed ID: 36116838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of serologic tests for lyme disease.
    Steere AC; McHugh G; Damle N; Sikand VK
    Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis.
    Busson L; Reynders M; Van den Wijngaert S; Dahma H; Decolvenaer M; Vasseur L; Vandenberg O
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):246-51. PubMed ID: 22560168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.